Northern Trust’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69.2M Sell
1,324,258
-7,942
-0.6% -$477K 0.01% 923
2025
Q4
$78.3M Sell
1,332,200
-89,513
-6% -$5.44M 0.01% 846
2025
Q3
$79.1M Sell
1,421,713
-3,805
-0.3% -$204K 0.01% 848
2025
Q2
$73.3M Sell
1,425,518
-192,441
-12% -$9.67M 0.01% 860
2025
Q1
$94.9M Sell
1,617,959
-43,995
-3% -$2.98M 0.01% 729
2024
Q4
$120M Buy
1,661,954
+293,193
+21% +$21.5M 0.02% 640
2024
Q3
$109M Sell
1,368,761
-142,501
-9% -$10.7M 0.02% 612
2024
Q2
$108M Sell
1,511,262
-23,040
-2% -$1.7M 0.02% 602
2024
Q1
$108M Sell
1,534,302
-63,241
-4% -$4.53M 0.02% 592
2023
Q4
$123M Sell
1,597,543
-29,530
-2% -$1.95M 0.02% 554
2023
Q3
$111M Buy
1,627,073
+38,223
+2% +$3.02M 0.02% 560
2023
Q2
$130M Sell
1,588,850
-18,871
-1% -$1.52M 0.02% 513
2023
Q1
$119M Sell
1,607,721
-43,747
-3% -$3.37M 0.02% 544
2022
Q4
$137M Buy
1,651,468
+50,008
+3% +$3.97M 0.03% 497
2022
Q3
$114M Sell
1,601,460
-54,212
-3% -$4.68M 0.03% 502
2022
Q2
$143M Sell
1,655,672
-109,684
-6% -$10.3M 0.03% 472
2022
Q1
$191M Sell
1,765,356
-11,288
-0.6% -$1.16M 0.03% 440
2021
Q4
$230M Sell
1,776,644
-15,180
-0.8% -$1.86M 0.04% 413
2021
Q3
$217M Buy
1,791,824
+102,080
+6% +$12.4M 0.04% 419
2021
Q2
$190M Buy
1,689,744
+223,008
+15% +$23.5M 0.03% 458
2021
Q1
$140M Buy
1,466,736
+48,576
+3% +$4.43M 0.03% 544
2020
Q4
$113M Buy
1,418,160
+2,540
+0.2% +$184K 0.02% 586
2020
Q3
$87.7M Sell
1,415,620
-34,944
-2% -$2.27M 0.02% 618
2020
Q2
$95.8M Buy
1,450,564
+67,916
+5% +$4.07M 0.02% 559
2020
Q1
$65.5M Buy
1,382,648
+44,128
+3% +$2.21M 0.02% 637
2019
Q4
$73.5M Buy
1,338,520
+28,352
+2% +$1.49M 0.02% 748
2019
Q3
$64.1M Sell
1,310,168
-17,456
-1% -$875K 0.02% 796
2019
Q2
$69.2M Sell
1,327,624
-17,284
-1% -$871K 0.02% 769
2019
Q1
$66.8M Buy
1,344,908
+31,944
+2% +$1.44M 0.02% 753
2018
Q4
$47.5M Sell
1,312,964
-96,468
-7% -$4.03M 0.01% 897
2018
Q3
$71.9M Sell
1,409,432
-75,216
-5% -$3.33M 0.02% 738
2018
Q2
$54.9M Sell
1,484,648
-33,040
-2% -$1.26M 0.01% 922
2018
Q1
$57.3M Sell
1,517,688
-1,644
-0.1% -$58.1K 0.01% 875
2017
Q4
$49.2M Sell
1,519,332
-189,056
-11% -$6.01M 0.01% 987
2017
Q3
$51.6M Sell
1,708,388
-159,848
-9% -$4.74M 0.01% 926
2017
Q2
$54.9M Sell
1,868,236
-87,644
-4% -$2.4M 0.02% 858
2017
Q1
$49.7M Buy
1,955,880
+396,356
+25% +$10.2M 0.01% 930
2016
Q4
$40.1M Sell
1,559,524
-502,032
-24% -$13.2M 0.01% 1055
2016
Q3
$56.4M Buy
2,061,556
+9,508
+0.5% +$261K 0.02% 777
2016
Q2
$57.9M Buy
2,052,048
+46,520
+2% +$1.2M 0.02% 730
2016
Q1
$47.1M Buy
2,005,528
+41,284
+2% +$909K 0.02% 845
2015
Q4
$44.2M Buy
1,964,244
+60,844
+3% +$1.39M 0.01% 897
2015
Q3
$44M Sell
1,903,400
-125,648
-6% -$3.15M 0.01% 894
2015
Q2
$50M Sell
2,029,048
-7,384
-0.4% -$184K 0.02% 861
2015
Q1
$51.1M Buy
2,036,432
+185,880
+10% +$4.42M 0.02% 844
2014
Q4
$42.7M Sell
1,850,552
-9,488
-0.5% -$217K 0.01% 952
2014
Q3
$43.5M Buy
1,860,040
+501,760
+37% +$11.8M 0.01% 892
2014
Q2
$31.4M Sell
1,358,280
-418,800
-24% -$9.25M 0.01% 1155
2014
Q1
$37.9M Buy
1,777,080
+439,372
+33% +$9.89M 0.01% 1037
2013
Q4
$31.7M Sell
1,337,708
-8,508
-0.6% -$184K 0.01% 1124
2013
Q3
$26.9M Sell
1,346,216
-32,184
-2% -$611K 0.01% 1217
2013
Q2
$23.8M Buy
+1,378,400
New +$22.9M 0.01% 1234

Other funds holding TECH

Northern Trust's TECH Position: Q1 2026 in Review

Northern Trust reduced its Bio-Techne (TECH) stake by 0.6% in Q1 2026, selling an estimated $477K and leaving 1,324,258 shares worth $69.2M. The position accounts for 0.01% of the portfolio, ranked #923.

Northern Trust first reported a position in TECH in Q2 2013 and has held it in 52 quarters since. The position peaked at $230M in Q4 2021. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Northern Trust held 1,324,258 shares of Bio-Techne worth $69.2M as of Q1 2026.
  • Northern Trust sold 7,942 Bio-Techne shares in Q1 2026, an estimated $477K.
  • Bio-Techne made up 0.01% of Northern Trust's portfolio in Q1 2026, its #923 holding.
  • Northern Trust first reported a position in Bio-Techne in Q2 2013 and has held it in 52 quarters since.
  • Northern Trust's Bio-Techne position peaked at $230M in Q4 2021.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.